Cited 14 times in
Nonspecific interstitial pneumonitis after bortezomib and thalidomide treatment in a multiple myeloma patient
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 강원석 | - |
dc.contributor.author | 김진석 | - |
dc.contributor.author | 박무석 | - |
dc.contributor.author | 장준 | - |
dc.date.accessioned | 2015-04-23T16:36:22Z | - |
dc.date.available | 2015-04-23T16:36:22Z | - |
dc.date.issued | 2010 | - |
dc.identifier.issn | 0513-5796 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/100888 | - |
dc.description.abstract | Bortezomib, an inhibitor of 26S proteosome, is recently approved treatment option for multiple myeloma. Thalidomide, a drug with immunomodulating and antiangiogenic effects, has also shown promise as an effective treatment in multiple myeloma. Pulmonary complications are believed to be rare, especially interstitial lung disease. Here, we describe a patient with dyspnea and diffuse pulmonary infiltrates while receiving bortezomib and thalidomide in combination with dexamethasone for treatment-naïve multiple myeloma. Bronchoalveolar lavage demonstrated a significant decrease in the ratio of CD4 : CD8 T lymphocytes (CD4/8 ratio, 0.54). Extensive workup for other causes, including infections, was negative. A lung biopsy under video-assisted thorascopic surgery revealed a diagnosis of nonspecific interstitial pneumonitis. The symptoms and imaging study findings improved after initiating steroid treatment. Physicians should be aware of this potential complication in patients receiving the novel molecular-targeted antineoplastic agents, bortezomib and thalidomide, who present with dyspnea and new pulmonary infiltrates and fail to improve despite treatment with broad-spectrum antibiotics | - |
dc.description.statementOfResponsibility | open | - |
dc.format | application/pdf | - |
dc.relation.isPartOf | YONSEI MEDICAL JOURNAL | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Boronic Acids/adverse effects* | - |
dc.subject.MESH | Boronic Acids/therapeutic use | - |
dc.subject.MESH | Bortezomib | - |
dc.subject.MESH | Dexamethasone/therapeutic use | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Lung Diseases, Interstitial/chemically induced* | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Multiple Myeloma/drug therapy* | - |
dc.subject.MESH | Pyrazines/adverse effects* | - |
dc.subject.MESH | Pyrazines/therapeutic use | - |
dc.subject.MESH | Thalidomide/adverse effects* | - |
dc.subject.MESH | Thalidomide/therapeutic use | - |
dc.title | Nonspecific interstitial pneumonitis after bortezomib and thalidomide treatment in a multiple myeloma patient | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Pathology (병리학) | - |
dc.contributor.googleauthor | Wonseok Kang | - |
dc.contributor.googleauthor | Jin Seok Kim | - |
dc.contributor.googleauthor | Sang Ho Cho | - |
dc.contributor.googleauthor | Sung Kyu Kim | - |
dc.contributor.googleauthor | Joon Chang | - |
dc.contributor.googleauthor | Moo Suk Park | - |
dc.identifier.doi | 10.3349/ymj.2010.51.3.448 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A00061 | - |
dc.contributor.localId | A01017 | - |
dc.contributor.localId | A01457 | - |
dc.contributor.localId | A03472 | - |
dc.contributor.localId | A03825 | - |
dc.relation.journalcode | J02813 | - |
dc.identifier.eissn | 1976-2437 | - |
dc.identifier.pmid | 20376900 | - |
dc.subject.keyword | Interstitial lung diseases | - |
dc.subject.keyword | thalidomide | - |
dc.subject.keyword | bortezomib | - |
dc.subject.keyword | multiple myeloma | - |
dc.subject.keyword | adverse effects | - |
dc.contributor.alternativeName | Kang, Won Suk | - |
dc.contributor.alternativeName | Kim, Jin Seok | - |
dc.contributor.alternativeName | Park, Moo Suk | - |
dc.contributor.alternativeName | Chang, Joon | - |
dc.contributor.affiliatedAuthor | Kang, Won Suk | - |
dc.contributor.affiliatedAuthor | Kim, Jin Seok | - |
dc.contributor.affiliatedAuthor | Park, Moo Suk | - |
dc.contributor.affiliatedAuthor | Chang, Joon | - |
dc.citation.volume | 51 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 448 | - |
dc.citation.endPage | 450 | - |
dc.identifier.bibliographicCitation | YONSEI MEDICAL JOURNAL, Vol.51(3) : 448-450, 2010 | - |
dc.identifier.rimsid | 55286 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.